MENU
+Compare
BGLAF
Stock ticker: OTC
AS OF
Dec 3 closing price
Price
$9.58
Change
-$0.92 (-8.76%)
Capitalization
1B

BGLAF Biogaia AB Forecast, Technical & Fundamental Analysis

BGLAF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for BGLAF with price predictions
Jan 08, 2025

BGLAF's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for BGLAF turned positive on December 20, 2024. Looking at past instances where BGLAF's MACD turned positive, the stock continued to rise in of 5 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis
Bearish Trend Analysis

The Aroon Indicator for BGLAF entered a downward trend on January 08, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.650) is normal, around the industry mean (58.527). P/E Ratio (25.575) is within average values for comparable stocks, (90.460). BGLAF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.947). Dividend Yield (0.014) settles around the average of (0.122) among similar stocks. P/S Ratio (8.772) is also within normal values, averaging (19.547).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. BGLAF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BGLAF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
BGLAF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
Kungsbroplan 3A
Phone
+46 855529300
Employees
212
Web
https://www.biogaia.se
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SEPCX9.980.07
+0.71%
Saratoga Energy & Basic Materials C
SMYIX24.860.17
+0.69%
Franklin Global Equity I
AVPAX23.760.15
+0.64%
American Beacon Small Cp Val Inv
PXIIX20.480.11
+0.54%
Virtus KAR Equity Income I
GGHCX36.56-0.21
-0.57%
Invesco Health Care A

BGLAF and Stocks

Correlation & Price change

A.I.dvisor tells us that BGLAF and SNOA have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BGLAF and SNOA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BGLAF
1D Price
Change %
BGLAF100%
N/A
SNOA - BGLAF
30%
Poorly correlated
-0.38%
CTTH - BGLAF
28%
Poorly correlated
+35.54%
CRYM - BGLAF
22%
Poorly correlated
N/A
SHPH - BGLAF
8%
Poorly correlated
-4.62%
DHBUF - BGLAF
5%
Poorly correlated
-0.94%
More

Groups containing BGLAF

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BGLAF
1D Price
Change %
BGLAF100%
N/A
Pharmaceuticals
category (309 stocks)
7%
Poorly correlated
+0.20%
Pharmaceuticals: Other
category (223 stocks)
6%
Poorly correlated
+0.11%